Company: BIVIW
Filing Date: 2025-10-06
Form Type: POS AM
Source: 0001520138-25-000294
Chunk: 2

Company: BIOVIE INC.
Filing Date: 2025-10-06
Form: POS AM
Chunk 2
---
 applicable registration fees were paid at the time of the original filing of the Registration Statement. The Company is filing this Amendment to (i) update the contents of the prospectus contained in the Registration Statement pursuant to Section 10(a)(3) of the Securities Act in respect of the continuous offering pursuant to Rule 415 of the shares of Common Stock described above, (ii) incorporate by reference the Company’s reports filed by the Company pursuant to the Securities and Exchange Act of 1934, as amended (the “Reports”), and (iii) to provide for forward incorporation by reference into the Registration Statement of Reports filed after the effective date of this Amendment, as permitted for smaller reporting companies (as defined in Rule 405 under the Securities Act) pursuant to Item 12(b) of Form S-1.

The information contained in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

380,000 Shares of Class A Common Stock Underlying Previously Issued Pre-Funded Warrants

6,000,000 Shares of Class A Common Stock Underlying Previously Issued Warrants

BioVie Inc.

This prospectus relates to the offer and sale by BioVie
Inc. of up to 380,000 shares of Class A Common Stock, par value $0.0001 per share (“Common Stock”), underlying pre-funded
warrants (“Pre-Funded Warrants”) and up to 6,000,000 shares of Common Stock underlying warrants (“Warrants”),
in each case previously issued by us in a firm commitment underwritten offering on August 11, 2025. The Pre-Funded Warrants are issuable
at a nominal exercise price of $0.0001 per share and the Warrants are issuable at an exercise price of $2.50 per share. We are not selling
any shares of our Common Stock in this offering other than pursuant to the exercise of outstanding Pre-Funded Warrants and Warrants. We
will receive proceeds of approximately $15.0 million if all of the currently outstanding Pre-Funded Warrants and Warrants are exercised.

Our Common Stock is listed on The Nasdaq Capital Market
(“Nasdaq”) under the symbol “BIVI” and the Warrants are listed on